Géraud Dautzenberg

Validating the MoCA for triaging 4 101 Given the results of our study, we recommend using the MoCA to exclude MD if someone scores 21 or above. Taking clinical and demographic factors such as FTD or very high levels of education into account (respectively 4.9% and 3.7% of our MD patients), the chance of this patient having MD is very low (NPV>94%). Although the absolute numbers of these outliers in our study were low, it confirms that MoCA tests results of patients with FTD or high education are prone to be false negative. The overlapping range of MoCA scores between groups in this study could be explained by individual differences such as FTD or PhD degrees (resulting in higher scores in the MD group), and poor motivation/concentration/attention due to mania or severe depression and schizophrenia (resulting in some lower scores in those with psychiatric illnesses) (Blair et al., 2016; Ramírez et al., 2014; Wu et al., 2017; Yoon et al., 2017). This underscores the importance of taking demographic and clinical factors into account when interpreting the MoCA results and not simply relying on the score, which is further emphasized by the finding that the MoCA score range of the SNoCI in this study (12-30) is smaller compared to our previous study (5-30) where the results of the initial assessment were not taken into account (Dautzenberg et al., 2020). It is reported that half of the patients with mild depression referred with cognitive complaints scored below 26 on the MoCA in a memory clinic (Blair et al., 2016). Another study reported that admitted schizophrenic patients had a mean MoCA score of 22 and 70% scored <26 (Wu et al., 2017). Their MoCA score was independent of their clinical state. A negative correlation between the cognitive part of the PANSS (assessing symptoms of schizophrenia) and the MoCA was found in another study with a mean MoCA of 23 (Ramírez et al., 2014). Our results, as underscored in the boxplot, are in line with these studies and showed the individual effect of psychiatric comorbidity. If one excludes all psychiatry, as often happens in studies, the higher scores of the comparisons will result in a better specificity, but would no longer represent the clinical reality. Referrals with cognitive complaints during, or possibly due to, psychiatric illnesses is the clinical reality and need to be differentiated. As neurodegenerative causes could still be a comorbidity or even the cause of this psychiatric illness considering their age. Excluding these patients could lead to a delayed diagnosis as (especially) depression or psychosis can be seen during early stage dementia. To find the optimal cutoff value we used the objective Youden J index, although the object and the setting can result in a different ‘best’ cutoff score. For differentiating between MD and no-dementia, cutoffs of <21 and <20 result in the same Youden score – however, the <21 cutoff has a sensitivity of 90% compared to 78% at <20, favoring the former when used as a screener. When

RkJQdWJsaXNoZXIy MTk4NDMw